The Effect of Symbiotic Beverage Consumption on Lipid Profile

The goal of this clinical trial is to evaluate whether the synbiotic beverage "Daygurt" can improve lipid profiles, blood sugar levels, blood pressure, and body weight in individuals diagnosed with dyslipidemia. The main questions it aims to answer are:

Does "Daygurt" significantly reduce total cholesterol and LDL levels compared to nutrition counseling alone? Does "Daygurt" increase HDL levels and reduce triglycerides more effectively than nutrition counseling? Does "Daygurt" lead to greater improvements in fasting blood sugar, blood pressure, and body weight compared to nutrition counseling?

The intervention group (receiving "Daygurt" plus nutrition counseling) will be compared to the comparison group (receiving nutrition counseling without "Daygurt") to see if "Daygurt" provides additional benefits beyond standard dietary advice.

Participants will be divided into 2 groups:

Intervention group: Consume "Daygurt" daily for 8 weeks. Comparison group: Receive nutrition counseling sessions focused on managing dyslipidemia but will not consume "Daygurt."

Both groups will undergo health parameter measurements before and after the intervention, including:

Total cholesterol, LDL, HDL, and triglyceride levels. Fasting blood sugar. Blood pressure. Body mass index (BMI).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Lipid Profile Body Mass Index Fasting Blood Sugar Above Normal

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Health Ministry Polytechnic of Padang

Padang, West Sumatra, 25146, Indonesia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Cholesterol total above 200 mg/dl, or LDL Cholesterol above 100, or BMI above 25 kg/m2
Agree to study protocols

Exclusion criteria

Has Allergic to dairy product
Having any drug lowering cholesterol

Treatment and study plan

SYMBIONIC

Dietary Supplement

Provision of 100 ml symbiotic beverages "daygurt" per day for 6 weeks, plus standard dietary advice for dyslipidemia

Dietary Advice

Behavioral

Participants get standard dietary advice for dyslipidemia

Primary outcomes

Lipid profile

Time frame: 6 weeks (before and after intervention)

Fasting Total blood cholesterol, LDL cholesterol, HDL cholesterol and triglyceride level measured before and after intervention phase

Sponsors and collaborators

Lead sponsor

Politeknik Kesehatan Kemenkes Padang

Other

Registry information

Official study title

The Effect of Symbiotic Beverage Consumption on Lipid Profile and Nutritional Status in Overweight and Hypercholesterolemia Adults Aged Above 18 Years

Acronym: SYMBIONIC

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Mar 25, 2025
Registry last updated: Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting